Verastem, Inc. (VSTM)
10.25
-0.11
(-1.06%)
USD |
NASDAQ |
Dec 08, 16:00
10.25
0.00 (0.00%)
After-Hours: 20:00
Verastem EPS Diluted (Quarterly): -1.347 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Anavex Life Sciences Corp. | -0.1144 |
| Ocugen, Inc. | -0.066 |
| Syndax Pharmaceuticals, Inc. | -0.7009 |
| AnaptysBio, Inc. | 0.5208 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -98.52M |
| Revenue (Quarterly) | 11.24M |
| Total Expenses (Quarterly) | 109.76M |
| Enterprise Value | 732.08M |
| Gross Profit Margin (Quarterly) | 82.57% |
| Profit Margin (Quarterly) | -876.3% |
| Earnings Yield | -41.55% |
| Normalized Earnings Yield | -32.01 |